Weili Zhu
No ORCID on file
· 5 papers in corpus
· active 2021-2025
Study types
- article 2
- other 1
- preprint 1
- rct 1
Condition tags
- adenomyosis 5
- dysmenorrhea 2
Top journals
Frequent coauthors
- Zhao W 4
- Yunyan Chen 4
- Jianzhang Wang 4
- Xuan Che 4
- Shao W 3
- Wang J 3
- Chen Y 3
- Jianqing Zhou 3
- Feiyun Zheng 2
- Danyang Zhu 2
other
2025
This study aimed to elucidate the role of microRNA-92a-3p (miR-92a-3p) in the pathogenesis of adenomyosis. We examined how miR-92a-3p, found in exosomes derived from ectopic lesions, influences the behaviour of endometrial cells, dorsal roo…
article
2024
To evaluate the clinical efficacy of etonogestrel subcutaneous implant (ENG-SCI) with that of the levonorgestrel-releasing intrauterine system (LNG-IUD) for adenomyosis treatment. A prospective randomized cohort study was conducted includin…
preprint
2024
Abstract This study aimed to elucidate the role of microRNA miR-92a-3p in the pathogenesis of adenomyosis. We focused on understanding how miR-92a-3p in exosomes derived from ectopic lesions influences the behavior of endometrial cells, DR…
rct
2023
IMPORTANCE: Adenomyosis is a common chronic gynecological disorder, and its treatment is an unmet need. New therapies need to be developed. Mifepristone is being tested for adenomyosis treatment. OBJECTIVE: To determine whether mifepriston…
article
2021